XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.21.4

Fair Value Measurements | 6 Months Ended
--- | ---
Nov. 30, 2021
Fair Value Disclosures [Abstract] |
Fair Value Measurements | NOTE 4 — FAIR VALUE MEASUREMENTS Financial instruments recorded in the balance sheet include cash and cash equivalents, trade accounts receivable, derivative assets and liabilities, marketable securities, notes and accounts payable, and debt. An allowance for credit losses is established for trade accounts receivable using assessments of current creditworthiness of customers, historical collection experience, the aging of receivables and other currently available evidence. Trade accounts receivable balances are written-off against the allowance if a final determination of uncollectibility is made. All provisions for allowance for doubtful collection of accounts are included in selling, general, and administrative expense. All derivative instruments are recognized in our Consolidated Balance Sheets and measured at fair value. Changes in the fair values of derivative instruments that do not qualify as hedges and/or any ineffective portion of hedges are recognized as a gain or (loss) in our Consolidated Statements of Income in the current period. Changes in the fair value of derivative instruments used effectively as cash flow hedges are recognized in other comprehensive income (loss), along with the change in the value of the hedged item. We do not hold or issue derivative instruments for speculative purposes. The valuation techniques utilized for establishing the fair values of assets and liabilities are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect management’s market assumptions. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value, as follows: Level 1 Inputs — Quoted prices for identical instruments in active markets. Level 2 Inputs — Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3 Inputs — Instruments with primarily unobservable value drivers. The following tables present our assets and liabilities that are measured at fair value on a recurring basis and are categorized using the fair value hierarchy. In addition, with respect to our derivative assets and liabilities measured at fair value, refer to Note 5, “Derivatives and Hedging” for discussion of their classification within the fair value hierarchy.
(In thousands) | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Fair Value at November 30, 2021 |
Available-for-sale debt securities: |  |  |  |  |  |  |  |
U.S. Treasury and other government | $ | - |  | $ | 26,718 |  | $ | - |  | $ | 26,718 |
Corporate bonds |  | - |  |  | 186 |  |  | - |  |  | 186 |
Total available-for-sale debt securities |  | - |  |  | 26,904 |  |  | - |  |  | 26,904 |
Marketable equity securities: |  |  |  |  |  |  |  |
Stocks - foreign |  | 986 |  |  | - |  |  | - |  |  | 986 |
Stocks - domestic |  | 7,176 |  |  | - |  |  | - |  |  | 7,176 |
Mutual funds - foreign |  | - |  |  | 45,142 |  |  | - |  |  | 45,142 |
Mutual funds - domestic |  | - |  |  | 90,108 |  |  | - |  |  | 90,108 |
Total marketable equity securities |  | 8,162 |  |  | 135,250 |  |  | - |  |  | 143,412 |
Contingent consideration |  | - |  |  | - |  |  | (9,806 | ) |  | (9,806 | )
Total | $ | 8,162 |  | $ | 162,154 |  | $ | (9,806 | ) | $ | 160,510 |
(In thousands) | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3) |  | Fair Value at May 31, 2021 |
Available-for-sale debt securities: |  |  |  |  |  |  |  |
U.S. Treasury and other government | $ | - |  | $ | 26,563 |  | $ | - |  | $ | 26,563 |
Corporate bonds |  | - |  |  | 182 |  |  | - |  |  | 182 |
Total available-for-sale debt securities |  | - |  |  | 26,745 |  |  | - |  |  | 26,745 |
Marketable equity securities: |  |  |  |  |  |  |  |
Stocks - foreign |  | 768 |  |  | - |  |  | - |  |  | 768 |
Stocks - domestic |  | 6,975 |  |  | - |  |  | - |  |  | 6,975 |
Mutual funds - foreign |  | - |  |  | 47,916 |  |  | - |  |  | 47,916 |
Mutual funds - domestic |  | - |  |  | 86,428 |  |  | - |  |  | 86,428 |
Total marketable equity securities |  | 7,743 |  |  | 134,344 |  |  | - |  |  | 142,087 |
Contingent consideration |  | - |  |  | - |  |  | (13,335 | ) |  | (13,335 | )
Total | $ | 7,743 |  | $ | 161,089 |  | $ | (13,335 | ) | $ | 155,497 |
Our investments in available-for-sale debt securities and marketable equity securities are valued using a market approach. The availability of inputs observable in the market varies from instrument to instrument and depends on a variety of factors, including the type of instrument, whether the instrument is actively traded and other characteristics particular to the transaction. For most of our financial instruments, pricing inputs are readily observable in the market, the valuation methodology used is widely accepted by market participants, and the valuation does not require significant management discretion. For other financial instruments, pricing inputs are less observable in the market and may require management judgment. The contingent consideration represents the estimated fair value of the additional variable cash consideration payable in connection with recent acquisitions that is contingent upon the achievement of certain performance milestones. We estimated the fair value using expected future cash flows over the period in which the obligation is expected to be settled, and applied a discount rate that appropriately captures a market participant's view of the risk associated with the obligation, which are considered to be Level 3 inputs. During the first half of fiscal 2022, we recorded an increase in the accrual for approximately $2.5 million related to fair value adjustments and paid approximately $5.7 million to satisfy contingent consideration obligations relating to certain performance milestones that were established in prior periods and achieved during the current year. During the first half of fiscal 2021, we paid approximately $2.8 million to satisfy contingent consideration obligations relating to certain performance milestones that were established in prior periods and achieved during the first half of last year, and recorded an increase in the accrual for approximately $2.7 million related to fair value adjustments. In the Consolidated Statements of Cash Flows, payments of acquisition-related contingent consideration for the amount recognized at fair value as of the acquisition date are reported in cash flows from financing activities, while payments of contingent consideration in excess of fair value as of the acquisition date, are reported in cash flows from operating activities. The carrying value of our current financial instruments, which include cash and cash equivalents, marketable securities, trade accounts receivable, accounts payable and short-term debt approximates fair value because of the short-term maturity of these financial instruments. At November 30, 2021 and May 31, 2021, the fair value of our long-term debt was estimated using active market quotes, based on our current incremental borrowing rates for similar types of borrowing arrangements, which are Level 2 inputs. Based on the analysis performed, the fair value and the carrying value of our financial instruments and long-term debt as of November 30, 2021 and May 31, 2021 are as follows:
|  | At November 30, 2021 |
(In thousands) |  | Carrying Value |  | Fair Value |
Cash and cash equivalents |  | $ | 192,851 |  | $ | 192,851 |
Marketable equity securities |  |  | 143,412 |  |  | 143,412 |
Available-for-sale debt securities |  |  | 26,904 |  |  | 26,904 |
Long-term debt, including current portion |  |  | 2,465,993 |  |  | 2,713,027 |
|  | At May 31, 2021 |
(In thousands) |  | Carrying Value |  | Fair Value |
Cash and cash equivalents |  | $ | 246,704 |  | $ | 246,704 |
Marketable equity securities |  |  | 142,087 |  |  | 142,087 |
Available-for-sale debt securities |  |  | 26,745 |  |  | 26,745 |
Long-term debt, including current portion |  |  | 2,379,826 |  |  | 2,570,206 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration